News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,008 Results
Type
Article (399)
Company Profile (2)
Press Release (16607)
Section
Business (9098)
Career Advice (7)
Deals (1092)
Drug Delivery (1)
Drug Development (1885)
FDA (226)
Job Trends (399)
News (11082)
Policy (413)
Tag
Academia (27)
Accelerated approval (4)
ADA (7)
Adcomms (1)
Allergies (1)
Alliances (361)
ALS (2)
Alzheimer's disease (68)
Antibody-drug conjugate (ADC) (5)
Approvals (251)
Artificial intelligence (4)
ASCO (7)
Autoimmune disease (8)
Automation (2)
Bankruptcy (14)
Best Places to Work (385)
BIO (1)
BIOSECURE Act (1)
Biosimilars (6)
Bladder cancer (8)
Breast cancer (14)
Cancer (173)
Cardiovascular disease (22)
Career advice (7)
CAR-T (4)
CDMO (1)
Cell therapy (9)
Cervical cancer (2)
Clinical research (1880)
Collaboration (30)
Compensation (13)
Complete response letters (2)
COVID-19 (44)
CRISPR (3)
C-suite (6)
Cystic fibrosis (2)
Data (403)
Depression (14)
Dermatology (4)
Diabetes (20)
Diagnostics (179)
Digital health (5)
Drug discovery (6)
Drug pricing (4)
Duchenne muscular dystrophy (8)
Earnings (9581)
Events (1370)
Executive appointments (9)
FDA (446)
Frontotemporal dementia (2)
Funding (24)
Gene editing (5)
Generative AI (1)
Gene therapy (11)
GLP-1 (34)
Government (39)
Guidances (125)
Healthcare (530)
Hematology (2)
HIV (4)
Huntington's disease (3)
IgA nephropathy (13)
Immunology and inflammation (14)
Immuno-oncology (3)
Indications (10)
Infectious disease (51)
Inflammatory bowel disease (6)
Influenza (1)
Intellectual property (4)
IPO (926)
Job creations (32)
Job search strategy (7)
Labor market (2)
Layoffs (14)
Legal (52)
Liver cancer (4)
Lung cancer (49)
Lymphoma (27)
Manufacturing (12)
MASH (9)
Medical device (427)
Medtech (440)
Mergers & acquisitions (192)
Metabolic disorders (57)
mRNA (3)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (115)
NextGen: Class of 2026 (121)
Non-profit (37)
Obesity (33)
Opinion (2)
Ovarian cancer (2)
Pain (12)
Pancreatic cancer (12)
Parkinson's disease (16)
Patents (10)
Patient recruitment (15)
Peanut (1)
People (340)
Peptides (1)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (411)
Phase 2 (790)
Phase 3 (879)
Pipeline (910)
Policy (2)
Postmarket research (66)
Preclinical (121)
Press Release (1)
Prostate cancer (11)
Psychedelics (4)
Radiopharmaceuticals (3)
Rare diseases (27)
Real estate (33)
Regulatory (444)
Reports (5)
Research institute (28)
RSV (5)
Schizophrenia (3)
Series A (4)
Series B (2)
Sickle cell disease (1)
Special edition (2)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (31)
Vaccines (18)
Venture capital (2)
Weight loss (17)
Women's health (3)
Date
Today (1)
Last 7 days (14)
Last 30 days (78)
Last 365 days (1248)
2026 (886)
2025 (1246)
2024 (1476)
2023 (1589)
2022 (1724)
2021 (1688)
2020 (1308)
2019 (919)
2018 (835)
2017 (711)
2016 (458)
2015 (690)
2014 (413)
2013 (256)
2012 (328)
2011 (328)
2010 (329)
Location
Africa (10)
Alabama (2)
Arizona (12)
Arkansas (1)
Asia (1473)
Australia (74)
California (691)
Canada (190)
China (38)
Colorado (25)
Connecticut (32)
Delaware (27)
Europe (2215)
Florida (98)
Georgia (26)
Illinois (69)
India (1)
Indiana (40)
Japan (21)
Kansas (4)
Kentucky (2)
Louisiana (5)
Maine (6)
Maryland (73)
Massachusetts (382)
Michigan (17)
Minnesota (42)
Mississippi (1)
Missouri (2)
Montana (2)
New Hampshire (2)
New Jersey (235)
New Mexico (1)
New York (130)
North Carolina (113)
Northern California (380)
Ohio (20)
Oregon (1)
Pennsylvania (128)
Puerto Rico (1)
South America (17)
South Carolina (1)
Southern California (244)
Tennessee (4)
Texas (75)
United States (2307)
Utah (22)
Virginia (6)
Washington D.C. (1)
Washington State (48)
Wisconsin (4)
17,008 Results for "104".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
August 25, 2026
·
7 min read
Press Releases
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
April 24, 2026
·
8 min read
Press Releases
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
June 30, 2026
·
10 min read
Press Releases
Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
April 13, 2026
·
3 min read
Press Releases
Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
April 29, 2026
·
3 min read
Press Releases
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
October 13, 2025
·
8 min read
Press Releases
U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status
February 23, 2026
·
3 min read
Press Releases
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
April 22, 2026
·
5 min read
Press Releases
EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting
April 14, 2026
·
3 min read
Press Releases
COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
March 3, 2026
·
4 min read
1 of 1,701
Next
